CSIMarket
 


Kempharm, Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Revenue Growth by Quarter and Year

Kempharm, Inc's Revenue results by quarter and year




KMPH Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - - - -
III Quarter September 11.46 - - -
II Quarter June - - - -
I Quarter March - - - -
FY   11.46 - - -



KMPH Revenue third quarter 2019 Y/Y Growth Comment
Kempharm, Inc in the third quarter achieved Revenue of $ 11.46 millions compare to recorded in same quarter a year ago.

According to the results reported in the third quarter, Kempharm, Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Kempharm, Inc' s Revenue no change of % ranks overall at the positon no. 0 in the third quarter.




KMPH Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kempharm, Inc's third quarter 2019 Revenue $ 11.46 millions KMPH's Income Statement
Kempharm, Inc's third quarter 2018 Revenue $ 0.00 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Revenue Growth >>


KMPH Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Kempharm, Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Revenue Comment


Kempharm, Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2019 period, Kempharm, Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Kempharm, Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2019 period, Kempharm, Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Kempharm, Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
KMPH's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for KMPH's Competitors
Revenue Growth for Kempharm, Inc's Suppliers
Revenue Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Vaso Corp -0.32 %$ -0.325 millions
Nature‚??s Sunshine Products,¬†inc. -0.34 %$ -0.342 millions
Myomo Inc -0.39 %$ -0.388 millions
Prestige Consumer Healthcare Inc. -0.54 %$ -0.538 millions
Dariohealth Corp. -0.59 %$ -0.585 millions
Alpha Pro Tech Ltd -0.64 %$ -0.636 millions
Vivus Inc -0.65 %$ -0.652 millions
Supernus Pharmaceuticals,¬†inc. -0.83 %$ -0.831 millions
Mednax, Inc. -0.89 %$ -0.890 millions
Atrion Corp -1.00 %$ -0.996 millions
Cool Holdings, Inc. -1.12 %$ -1.121 millions
Livanova Plc -1.28 %$ -1.276 millions
Assembly Biosciences,¬†inc. -1.28 %$ -1.280 millions
Magellan Health,¬†inc. -1.33 %$ -1.325 millions
Petmed Express Inc -2.04 %$ -2.045 millions
Endo International Plc -2.15 %$ -2.152 millions
Intersect Ent, Inc. -2.47 %$ -2.473 millions
Nymox Pharmaceutical Corporation -2.50 %$ -2.500 millions
Owens¬†& Minor, Inc. -2.67 %$ -2.672 millions
United Therapeutics Corporation -2.71 %$ -2.714 millions
Arcturus Therapeutics Holdings Inc. -3.07 %$ -3.067 millions
Invacare Corporation -3.59 %$ -3.592 millions
Advansource Biomaterials Corporation -3.90 %$ -3.904 millions
Capital Senior Living Corp -3.93 %$ -3.926 millions
Pressure Biosciences Inc -3.95 %$ -3.950 millions
Dynatronics Corp -3.96 %$ -3.963 millions
China Health Industries Holdings, Inc. -4.10 %$ -4.104 millions
Harvard Bioscience Inc -4.25 %$ -4.250 millions
Geovax Labs, Inc. -4.62 %$ -4.619 millions
Cleveland Biolabs Inc -4.83 %$ -4.826 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AEL's Profile

Stock Price

AEL's Financials

Business Description

Fundamentals

Charts & Quotes

AEL's News

Suppliers

AEL's Competitors

Customers & Markets

Economic Indicators

AEL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071